Association of Serum Retinol Binding Protein 4 with Atherogenic Dyslipidemia in Morbid Obese Patients

• Milagros Rocha ,

  * E-mail: milagros.rocha@uv.es

  Affiliations Service of Endocrinology, University Hospital Dr. Peset, Valencia, Spain, Foundation for the Promotion of Healthcare and Biomedical Research in the Valencian Community (FISABIO), Valencia, Spain, CIBER CB06/04/0071 Research Group. CIBER Hepatic and Digestive Diseases, Faculty of Medicine, University of Valencia, Valencia, Spain, Institute of Health Research INCLIVA, Valencia, Spain

  ⨯
• Celia Bañuls,

  Affiliations Service of Endocrinology, University Hospital Dr. Peset, Valencia, Spain, Institute of Health Research INCLIVA, Valencia, Spain, Department of Medicine, Faculty of Medicine, University of Valencia, Valencia, Spain

  ⨯
• Lorena Bellod,

  Affiliations Service of Endocrinology, University Hospital Dr. Peset, Valencia, Spain, Foundation for the Promotion of Healthcare and Biomedical Research in the Valencian Community (FISABIO), Valencia, Spain, Institute of Health Research INCLIVA, Valencia, Spain

  ⨯
• Susana Rovira-Llopis,

  Affiliations Service of Endocrinology, University Hospital Dr. Peset, Valencia, Spain, Foundation for the Promotion of Healthcare and Biomedical Research in the Valencian Community (FISABIO), Valencia, Spain

  ⨯
• Carlos Morillas,

  Affiliations Service of Endocrinology, University Hospital Dr. Peset, Valencia, Spain, Foundation for the Promotion of Healthcare and Biomedical Research in the Valencian Community (FISABIO), Valencia, Spain, Institute of Health Research INCLIVA, Valencia, Spain, Department of Medicine, Faculty of Medicine, University of Valencia, Valencia, Spain

  ⨯
• Eva Solá,

  Affiliations Service of Endocrinology, University Hospital Dr. Peset, Valencia, Spain, Foundation for the Promotion of Healthcare and Biomedical Research in the Valencian Community (FISABIO), Valencia, Spain, Institute of Health Research INCLIVA, Valencia, Spain, Department of Medicine, Faculty of Medicine, University of Valencia, Valencia, Spain

  ⨯
• Víctor M. Víctor,

  Affiliations Service of Endocrinology, University Hospital Dr. Peset, Valencia, Spain, Foundation for the Promotion of Healthcare and Biomedical Research in the Valencian Community (FISABIO), Valencia, Spain, CIBER CB06/04/0071 Research Group. CIBER Hepatic and Digestive Diseases, Faculty of Medicine, University of Valencia, Valencia, Spain, Institute of Health Research INCLIVA, Valencia, Spain, Department of Physiology, Faculty of Medicine, University of Valencia, Valencia, Spain

  ⨯
• Antonio Hernández-Mijares

  Affiliations Service of Endocrinology, University Hospital Dr. Peset, Valencia, Spain, Foundation for the Promotion of Healthcare and Biomedical Research in the Valencian Community (FISABIO), Valencia, Spain, Institute of Health Research INCLIVA, Valencia, Spain, Department of Medicine, Faculty of Medicine, University of Valencia, Valencia, Spain

  ⨯